Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer

Código QR

Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer

Abstract This systematic review and cumulative analysis aimed to explore the efficacy and safety of the combination of intravesical mitomycin C (MMC) plus bacillus Calmette-Guerin (BCG) for non-muscle-invasive bladder cancer (NMIBC) patients. A comprehensive literature search using Pubmed, Embase, M...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tuo Deng, Bing Liu, Xiaolu Duan, Tao Zhang, Chao Cai, Guohua Zeng
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cd0b2ffac63d428fafd46ceb69e03ecd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Oral vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
por: Mitchell V Palmer, et al.
Publicado: (2014)

Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Hongda Zhao, et al.
Publicado: (2021)

An ambivalent prostate nodule after Bacillus Calmette-Guérin therapy
por: L. Sauvat, et al.
Publicado: (2021)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
por: Junli Li, et al.
Publicado: (2021)

An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
por: Seyed Saeed Tamehri Zadeh, et al.
Publicado: (2020)

Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination
por: Sayori Kobayashi, et al.
Publicado: (2021)

Espondilodiscitis con absceso intrarraquídeo y paraespinal causada por bacilo de Calmette-Guérin (BCG)
por: Lara-Oya,Ana, et al.
Publicado: (2015)

Bacillus Calmette-Guérin Vaccine-Induced Lupus Vulgaris in a Child with Bronchial Asthma
por: Abdullah Abualiat, et al.
Publicado: (2021)

Bacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.
por: Christine Deffert, et al.
Publicado: (2014)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
por: Helen A. Fletcher
Publicado: (2016)

Short- and Long-Term Effects of Vitamin D Treatment on Bacillus Calmette-Guerin-Induced Depressive-Like Behavior in Mice
por: Saleh LA, et al.
Publicado: (2021)

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
por: Joshua S. Woodworth, et al.
Publicado: (2021)

Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy
por: Laure Doisy, et al.
Publicado: (2021)

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain
por: Ana Plata, et al.
Publicado: (2021)

Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
por: Yu-Ching Wen, et al.
Publicado: (2021)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021)

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Bum Sik Tae, et al.
Publicado: (2017)

Enfermedad por bacilo de Calmette-Guérin (BCG) y deficiencia del receptor β-1 de interleuquina 12: Experiencia clínica de dos casos en una familia y un caso aislado
por: Strickler,Alexis, et al.
Publicado: (2014)

Development of a Counterselectable Transposon To Create Markerless Knockouts from an 18,432-Clone Ordered <named-content content-type="genus-species">Mycobacterium bovis</named-content> Bacillus Calmette-Guérin Mutant Resource
por: Katlyn Borgers, et al.
Publicado: (2020)

The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning
por: Nathan A. Brooks, et al.
Publicado: (2021)

The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
por: Zhang Zhiyu, et al.
Publicado: (2021)

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
por: David Liu, et al.
Publicado: (2017)

NON-INVASIVE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER IN PATIENTS WITH DERANGED RENAL PROFILE
por: Muhammad Adnan Zeb, et al.
Publicado: (2018)

[53] Neutrophil-to-lymphocyte ratio in non-muscle-invasive bladder cancer
por: Anés Sempere, et al.
Publicado: (2018)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Won Sik Ham, et al.
Publicado: (2021)

Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer
por: Daniel Balan, et al.
Publicado: (2021)

Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
por: Smilowitz HM, et al.
Publicado: (2017)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Mi Ah Han, et al.
Publicado: (2021)

Dietary Pyridoxine Controls Efficacy of Vitamin B<sub>6</sub>-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Δ<italic toggle="yes">pdx1</italic> in Mice
por: Martin Gengenbacher, et al.
Publicado: (2014)

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
por: K. M. Patel, et al.
Publicado: (2017)

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
por: Markus Eckstein, et al.
Publicado: (2021)

Single-Cell Proteomic Analysis Dissects the Complexity of Tumor Microenvironment in Muscle Invasive Bladder Cancer
por: Chao Feng, et al.
Publicado: (2021)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Sebastien Rinaldetti, et al.
Publicado: (2020)

[2] Neoadjuvant intravesical chemotherapy to treat extended large non-muscle-invasive bladder cancer
por: Marco Raber, et al.
Publicado: (2018)

Muscle non-invasive bladder cancer: clinical and morphological features, treatment outcomes, survival analysis
por: K. B. Lelyavin, et al.
Publicado: (2013)

Levofloxacin-Loaded Nanosonosensitizer as a Highly Efficient Therapy for Bacillus Calmette-Guérin Infections Based on Bacteria-Specific Labeling and Sonotheranostic Strategy
por: Li G, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis Protocol of Chemoablation vs. Transurethral Resection of Bladder Tumor in Patients With Non-Muscle-Invasive Bladder Cancer
por: Xu Shi, et al.
Publicado: (2021)

Spheroids of Bladder Smooth Muscle Cells for Bladder Tissue Engineering
por: Tim Gerwinn, et al.
Publicado: (2021)

Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer
por: Lingling Qi, et al.
Publicado: (2021)

Gene regulatory networks analysis of muscle-invasive bladder cancer subtypes using differential graphical model
por: Yongqing Zhang, et al.
Publicado: (2021)